NEOPHARM revenue for the last year amounted to 97.10 B KRW, the most of which — 96.27 B KRW — came from its highest performing source at the moment, Cosmetics Product, the year earlier bringing 83.89 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought NEOPHARM 97.10 B KRW, and the year before that — 84.21 B KRW.